Company Filing History:
Years Active: 2016
Title: Manuela Avi - Innovator in Enzymatic Production of Carnitine
Introduction
Manuela Avi is a notable inventor based in Kufstein, Austria. She has made significant contributions to the field of biochemistry, particularly in the enzymatic production of L-carnitine. Her innovative approach has the potential to impact various applications in health and nutrition.
Latest Patents
Manuela Avi holds a patent for a process for the enzymatic production of carnitine from beta-lactones. This patent, which is a crucial advancement in the production of L-carnitine, involves converting a β-lactone, specifically a 4-(halomethyl)oxetane-2-one, into L-carnitine. The process includes an enzymatic conversion of the β-lactone into (R)-4-halo-3-hydroxybutyric acid or (R)-4-halo-3-hydroxybutyric acid ester. This innovative method showcases her expertise in enzymatic processes and their applications.
Career Highlights
Manuela Avi is currently employed at Lonza Inc., a leading global company in the life sciences sector. Her work at Lonza has allowed her to collaborate with other experts in the field and contribute to groundbreaking research and development projects.
Collaborations
One of her notable coworkers is Ellen Klegraf, who is also involved in innovative projects at Lonza Inc. Their collaboration exemplifies the teamwork and synergy that drive advancements in scientific research.
Conclusion
Manuela Avi's contributions to the enzymatic production of carnitine highlight her role as an influential inventor in the field of biochemistry. Her patent and work at Lonza Inc. demonstrate her commitment to innovation and the advancement of health-related applications.